DNA glycosylase Neil3 regulates vascular smooth muscle cell biology during atherosclerosis development

Ana Quiles-Jimenez, Ida Gregersen, Filip M. Segers, Tonje Skarpengland, Penelope Kroustallaki, Kuan Yang, Xiang Yi Kong, Knut H. Lauritzen, Maria B. Olsen, Tom Rune Karlsen, Tuula A. Nyman, Ellen L. Sagen, Vigdis Bjerkeli, Rajikala Suganthan, Stale Nygard, Katja Scheffler, Jurrien Prins, Eric Van der Veer, Jonas D. S. Ogaard, Yngvar FloisandHelle F. Jorgensen, Kirsten B. Holven, Erik A. Biessen, Hilde Nilsen, Tuva B. Dahl, Sverre Holm, Martin R. Bennett, Pal Aukrust, Magnar Bjoras, Bente Halvorsen*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Web of Science)
Original languageEnglish
Pages (from-to)123-132
Number of pages10
JournalAtherosclerosis
Volume324
DOIs
Publication statusPublished - May 2021

Keywords

  • Atherosclerosis
  • NEIL3
  • DNA damage repair
  • Vascular smooth muscle cells
  • Phenotypic transdifferentiation
  • Akt signaling
  • IN-VITRO
  • PROLIFERATION
  • REPAIR
  • DAMAGE
  • RESPONSES
  • RISK
  • AKT

Cite this